Increase flexibility in managing s75 (extension of term for pharmaceutical patents) oppositions

At a glance

Policy ID: 99

Status: On hold

Priority: Low


Issue summary

This proposal would re-categorise oppositions to the extension of term of pharmaceutical patents under section 75 of the Patents Act as procedural, rather than substantive, oppositions. This will allow for efficient and flexible management of evidentiary periods by direction, and ensure that such oppositions are dealt with expeditiously, minimising uncertainty regarding the expiry date of high value patents.


On hold 8 August 2019


Issue to be considered in future. Other matters of higher priority will be considered first.

Policy feedback

You can provide feedback on this policy through the form below.


By clicking the submit button below, you consent to any personal information you provide through this form being handled in accordance with the IP Australia Privacy Policy.